A systematic study of molecular targets of cannabidiol in Alzheimer’s disease

Abstract Background: Alzheimer’s disease (AD) is a prevalent, incurable, and chronic neurodegenerative condition characterized by the accumulation of amyloid-β protein (Aβ), disrupting various bodily systems. Despite the lack of a cure, phenolic compounds like cannabidiol (CBD), a non-psychoactive component of cannabis, have emerged as potential therapeutic agents for AD. Objective: This systematic review explores the impact of different types of cannabidiol on AD, unveiling their neuroprotective mechanisms. Methods: The research used PubMed, Scopus, and Web of Science databases with keywords